Healthcare
Reston Hospital has received verification as a Level II Trauma Center by the American College of Surgeons for a period of three years through the year 2022.
Follows recent study results showing CelGro® facilitates high quality nerve repair and restores function to previously paralysed muscles
IBA, the world’s leading provider of solutions for the diagnosis and treatment of cancer, announces that it has sold RadioMed Corporation, IBA’s VISICOIL™ fiducial markers business, to IZI Medical Products LLC, a leading interventional medical device company in a deal that is worth between USD 14 and 16 million to IBA.
Verily, an Alphabet company, is partnering with Wake Forest Baptist Health and its Center for Healthcare Innovation to implement new solutions to improve the health and wellness of older adults and help them remain independent at home.
The National Eye Hospital of the Quinze- Vingts in Paris and GenSight Biologics announced that the French Competent Authority, the National Drug Safety Agency, granted a named patient Temporary Authorization for Use for LUMEVOQTM to the CHNO of the Quinze-Vingts.
Use of innovative technology in the treatment of brain tumor patients, now also in Zwickau, the central treatment center in East Germany.
Fundraising will support the expansion of Hummingbird Bioscience’s discovery pipeline and rapid development of its portfolio of targeted antibody therapeutics
Changes in heart rate, due to low oxygen conditions, experienced by the fetus during pregnancy, could be used to predict the future heart health of babies, shows research published in The Journal of Physiology.
Clinical-stage immuno-oncology company Agenus builds on Genedata’s E2E biopharma discovery system to streamline cancer immunotherapy R&D
Elucid is continuing a series of robustness tests on its smart pill bottle – Pill Connect – which have reported 100 % reliability.
PRESS RELEASES